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Key messages 
Combined whole genome sequencing data and patient questionnaire data allows enhanced 
understanding of gonorrhoea transmission. 
 
Gonorrhoea transmission networks include patients of mixed HIV-serostatus: serosorting may be 
declining as a practice. 
 
Public health interventions should be designed to minimise the risk of disease transmission associated 
with use of recreational drugs (“chemsex”) and use of geosocial networking applications to facilitate 
contact with partners. 
 
 
 
Legend to Figures and Tables. 
 
 
Figure 1. Maximum likelihood recombination-corrected phylogenetic tree of 84 
genetically distinct infections identified in 83 individuals with whole genome sequencing 
data and questionnaire data. The tips of the tree are labelled with transmission cluster 
identifiers (A-Z, a-m) based on transmission clusters identified in 10. Five clusters with three 
or more cases with questionnaire data are highlighted. A single isolate for each patient 
infection is shown. 
 
Figure 2.  Maximum likelihood recombination-corrected phylogenetic trees of 
transmission clusters 1-3.  Where more than one sequence was available from a patient, all 
are shown. 
 
Table 1.  Anatomical sites of infection in MSM 
 
Table 2.  Patient characteristics and behavioural information for 14 clusters of patients 
linked by WGS data.  *one patient did not report sexual orientation 
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Abstract 
 
Objectives 
Prevention and control of gonorrhoea depends on understanding the nature of sexual networks and 
risk factors for infection.  We aimed to use high resolution typing (whole genome sequencing) of 
Neisseria gonorrhoeae isolates plus patient questionnaire data to gain insights into transmission 
patterns in a high prevalence setting. 
Methods 
During a nine month period (July 2014-March 2015) patients diagnosed with gonorrhoea attending 
sexual health service in Brighton, UK, were invited to provide anonymised detailed information by 
questionnaire about risk factors for infection.  Questionnaire data plus whole genome sequence data 
from cultured isolates were analysed to yield information about sexual networks and risk factors for 
infection.    
Results 
104/149 individuals who consented to participate in the study were culture-positive. 97/104 (93%) 
were male.  80 self-reported to be men who have sex with men (MSM).  35/104 (34%) of patients 
were HIV-positive. 51/104 (49%) individuals reported using geosocial networking applications to 
facilitate contact.  Sex under the influence of drugs was reported by 16/34 (46%) of HIV-positive 
MSM, 17/41 (41%) of HIV-negative MSM and 5/15 (31%) of heterosexuals.  WGS data were 
available for 100 isolates from 83 patients.  55 isolates (66%) belonged to genetically related subtypes 
involving one or more patients, who could be plausibly linked through recent direct or indirect 
transmission.  Four transmission clusters containing 3-12 individuals were composed of MSM of 
mixed HIV-serostatus. 
Conclusions 
We show that data obtained from whole genome sequencing of Neisseria gonorrhoeae and enhanced 
epidemiological data obtained from patient questionnaires are mutually supportive and reveal insights 
into sexual networks.  Our findings suggest that serosorting may have declined as a practice and 
indicate the importance of designing public health interventions that target infection risks associated 
with recreational drug use and contact made using geosocial networking applications. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Introduction 
 
Gonorrhoea is of public health concern globally, with 78 million cases occurring annually and 
increasing rates of antimicrobial resistance¹. Between 2014 and 2015, the annual incidence rose in 
England by 11% from 37,100 to 41,193 reported cases². In the USA almost 400,000 cases were 
reported in 2015, a 12.8% increase from 2014³. Gonorrhoea is associated with significant morbidity 
including pelvic inflammatory disease and tubal factor infertility in women and epididymo-orchitis in 
men.  
 
Gonorrhoea control depends on effective prevention, reliable diagnostics and prompt antimicrobial 
treatment of the index patient and recent sexual contacts.  Asymptomatic carriage of Neisseria 
gonorrhoeae, especially in the rectum and pharynx, facilitates onward transmission, and therefore, 
frequent screening is recommended. For high-risk individuals, such as men who have sex with men 
(MSM), this is recommended every three months4. However, despite evidence of increased access and 
engagement with sexual health services, gonorrhoea incidence is rising, particularly amongst MSM³. 
Several possible drivers may explain this increase. Firstly, the widespread use of online and mobile 
phone geosocial networking applications to facilitate contact may increase the number of casual sex 
partners and has been associated with sexually transmitted infection (STI) outbreaks5,6. Secondly, 
“chemsex,” which is associated with disinhibitory behaviour and prolonged episodes of condom-less 
sex with multiple partners, has become increasingly popular5,6,7. Thirdly, concern about HIV 
acquisition may have diminished with increasing availability of HIV pre-exposure prophylaxis8 and 
perceptions that effective antiretroviral therapy prevents onward transmission to HIV-negative 
partners9.  
 
Understanding the networks within which gonorrhoea is transmitted is of crucial importance for 
directing public health interventions, where success depends on targeting effective interventions at 
appropriate individuals. N. gonorrhoeae multi-antigen sequence typing (NG-MAST) has previously 
been used to identify strains associated with different populations but lacks the precision to link 
individuals, whereas whole genome sequencing (WGS) is more discriminatory and reveals networks 
of individuals infected with genetically related isolates10,11. Combined with epidemiological data 
WGS has the potential to shed light on local and global epidemiology of gonorrhoea.  
 
We aimed to test the feasibility of using WGS data coupled with patient questionnaire data from a 
sexual health clinic to investigate and characterise transmission networks in a high prevalence setting. 
 
 
 
  
Methods 
 
Setting and participants 
Brighton Sexual Health and Contraception centre has approximately 25,000 attendances a year of 
which 25% are MSM. In a prospective observational study all attendees, over a nine month period 
(July 2014-March 2015, inclusive), with confirmed gonorrhoea on either nucleic acid amplification 
test (NAAT; BD ProbeTec, BD, Franklin Lakes, NJ, USA) or microscopy were invited to enter the 
study and complete a detailed questionnaire (see supplementary materials) on sexual behaviour and 
lifestyle.  Patients with gonorrhoea were treated with ceftriaxone plus azithromycin.  Ethical approval 
was obtained from Brighton and Sussex Research Ethics Committee (14/LO/0435) to collect 
anonymised data from patients and invite them to complete a questionnaire. The questionnaire was 
developed in consultation with local practitioners with reference to the British National Survey of 
Sexual Attitudes and Lifestyles for rapid completion in the clinic to capture key information about 
infection risk factors.  Individual consent for the use of anonymised bacterial isolates was not 
required. 
 
Samples 
Urogenital, rectal or pharyngeal samples were obtained as part of routine sexual health testing. Study 
isolates of N. gonorrhoeae (VCAT selective-agar, Oxoid, Basingstoke, UK) at Royal Sussex County 
Hospital laboratory underwent WGS as part of a previously published study10. 
 
Procedures 
Laboratory and sequencing procedures have been previously described in detail10. Samples were 
processed in a routine diagnostic laboratory where isolates were identified and antibiotic 
susceptibilities were determined.  A sweep of colonies from culture-positive selective agar plates 
underwent Illumina (San Diego, CA, USA) WGS. Sequence data were mapped to the Neisseria 
gonorrhoeae NCCP11945 reference genome and variants identified and compared with single 
nucleotide polymorphisms (SNPs) obtained from maximum likelihood phylogenetic trees, adjusted 
from the impact of recombination with ClonalFrameML12.  Sequence data (see supplementary 
materials) were deposited at the National Center for Biotechnology Information (NCBI).  Isolates 
were assigned to subtypes, related by recent direct or indirect transmission, using a transmission 
nomogram, described elsewhere10, taking into account genetic relatedness of isolates as well as 
sampling dates.  The nomogram gives the expected range in genetic difference (single nucleotide 
polymorphisms, SNPs) between isolates that includes 99% of direct or indirect transmissions for a 
given time (e.g. 0-11 SNPs for samples taken six months apart). When identifying transmission 
clusters, all previously sequenced isolates were considered, including those without questionnaire 
data, however, only isolates from patients with questionnaire data are depicted in the current study. 
Sequenced isolates from the same patient that were not related by transmission using the transmission 
nomogram were considered to be distinct infections.  
 
Consenting individuals completed a two-page questionnaire with information about their sexual 
history, condom use, STI history, use of internet/mobile phone apps to facilitate sex, travel history, 
recreational drug and alcohol consumption. Data collected were analysed using IBM SPSS Statistics 
(version 22).  
 
Results 
339 patients were NAAT-positive for N. gonorrhoeae during the study period. 149 (44%) individuals 
consented to participate in the study.  45/149 (30%) patients were culture-negative.  Questionnaire 
data were analysed for the 104/149 (70%) individuals with a positive N. gonorrhoeae culture.    
97/104 (93%) of patients were male, and 90/104 (87%) were white.  Median age was 35 years old 
(range 20-61 years), and the most represented age group was 25-44yrs (70%). 35/104 (34%) of 
patients were HIV-positive.  Sexual orientation was: MSM, 80/104 (77%); bisexual, 6/104 (6%); 
heterosexual, 15/104 (14%); unreported, 3/104 (3%). WGS data were available, from a previous 
transmission study,10 for 100 isolates from  83/104 (80%) patients.  
 
Sexual behaviour 
The median number of sexual partners in the past 3 months was 1 (range: 1-23) for heterosexuals, 5 
(range: 1-45) for HIV-positive MSM and 5 for HIV-negative MSM (range 1-30). 51/104 (49%) 
individuals reported using geosocial networking applications to facilitate contact with partners.  
Overall, condom usage in the preceding 3 months was reported as: always by 16/86 (19%), sometimes 
47 (54%), and never by 18 (21%). 
 
Recreational drug use 
Sex under the influence of drugs was reported by 16/34 (46%) of HIV-positive MSM, 17/41 (41%) of 
HIV-negative MSM and 5/15 (33%) of heterosexuals. Mephedrone and cocaine were frequently cited 
by MSM and heterosexuals respectively. Ten (6 HIV-positive) MSM reported “slamming” (injecting 
drugs at the time of sex) in the previous 3 months.  
 
Site of infection 
45/104 (43%) individuals had rectal infection, 20/104 (19%) had pharyngeal infection, 53/104 (51%) 
had urethral infection and 7/104 (7%) had cervical infection. Many individuals were simultaneously 
infected at multiple sites.  Sites of infection in MSM are shown in Table 1.  
 
Table 1.  Anatomical sites of infection in MSM 
 
Site Number of patients 
Rectum only 31 
Urethra only 30 
Throat only 11 
Rectum + Urethra 7 
Rectum + Throat 4 
Rectum + Urethra + Throat 1 
Urethra + Throat 2 
Total  86 
 
 
Genomic analysis 
From 100 sequenced isolates, we identified 84 genetically distinct infections in 83 patients, caused by 
44 distinct genetic subtypes of N. gonorrhoeae, where isolates within a subtype were related by direct 
(person-to-person) or indirect (via ≥1 intermediate source) transmission (Figure 1). 28 subtypes were 
identified in a single infected patient, and could not be linked to others within this particular data set. 
The remaining 56 infections (67%) belonged to subtypes represented by 14 clusters of two or more 
isolates where infected patients could be plausibly linked to one or more others.  Patient 
characteristics and behavioural information for these clusters are given in Table 2. 
 
 
Table 2.  Patient characteristics and behavioural information for 14 clusters of patients linked 
by WGS data.  *one patient did not report sexual orientation 
   
Cluster  1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Number of 
patients 
12 11 4 3 4 2 2 2 2 2 2 2 2 2 
MSM/bisexual: 
heterosexual 
12:0 11:0 1:3 3:0 3:0* 2:0 2:0 2:0 2:0 2:0 2:0 2:0 2:0 2:0 
HIV +ve : 
HIV-ve 
6:6 4:7 0:4 2:1 3:1 0:2 0:2 2:0 0:2 0:2 0:2 2:0 2:0 2:0 
Reported 
chemsex 
5/12 7/11 1/4 1/3 3/4 1/2 0/2 0/2 2/2 0/2 0/2 1/2 0/2 1/2 
Reported 
mobile phone 
app use 
5/12 6/11 2/4 2/3 3/4 2/2 2/2 2/2 1/2 0/2 1/2 1/2 1/2 2/2 
Reported 
condom-less 
sex 
7/12 8/11 3/4 3/3 3/4 2/2 1/2 2/2 2/2 2/2 2/2 2/2 1/2 2/2 
 
 
Cluster 1 
The largest cluster (Figure 2) comprised 12 MSM, of whom six were HIV-positive and six HIV-
negative. Five individuals were infected at more than one anatomical site; rectum (n=9), urethra (n=5) 
and pharynx (n=3). One individual in this cluster with rectal infection yielded a genetically unrelated 
strain from a urethral sample and belonged simultaneously to two separate transmission networks. 
Individual sexual practice was diverse, with the majority practising insertive (9/12) and receptive 
(10/12) anal intercourse and active (11/12) and receptive fellatio (10/12).  5/12 patients reported 
chemsex (defined as use of γ-hydroxybutyrate, 4-methylmethcathinone, or methamphetamine to 
facilitate or enhance sex), including one individual who reported injecting drug use at the time of sex. 
Condom use was recorded as: always by 4/12, sometimes by 4/12, never by 3/12 and unreported by 
1/12. To facilitate contact, 4/12 had visited a sauna, 4/12 attended sex parties (4/12) and 5/12 used 
mobile phone apps. During the preceding 3 months 7 individuals reported sex outside Brighton: 
London (5/12), Spain (1/12) and Germany (1/12); the remainder reported sex only in Brighton.  
 
 
Cluster 2 
The second largest cluster (Figure 2) comprised 4 HIV-positive MSM and 7 HIV-negative MSM. 
Three were infected at more than one anatomical site.  Infection sites were: urethra (n=6), rectum 
(n=5), pharynx (n=3). Sexual practice was diverse with the majority practising receptive (8/11) and 
insertive (10/11) anal intercourse, and active and receptive fellatio (11/11). Condom use was reported 
as: always by 3/11, sometimes by 6/11 and never by 2/11.  6/11 reported use of mobile phone apps to 
facilitate sex, 3/11 had visited saunas and 6/11 had attended sex parties. 7/11 reported chemsex, 
(including slamming by one individual).  
 
 
Cluster 3 
A smaller cluster (Figure 2) comprised three self-reported heterosexual males and one MSM; all HIV 
negative with urethral infection. 2/4 individuals reported using mobile phone apps. The heterosexual 
males reported insertive vaginal intercourse and active and receptive oral sex. The MSM reported 
insertive and receptive anal and oral intercourse. Chemsex was reported only by the MSM. Condom 
use was recorded as: never by 1/4, sometimes by 2/4 and unreported by 1/4. The MSM reported sex in 
Manchester and the USA.  
 
 
Two smaller clusters (cluster 4, n=3) and cluster 5, n=4) both comprised individuals of mixed HIV 
serostatus (Figure 1).  Most of these individuals reported mobile phone app use to make contact and 
chemsex.   
 
 
Discussion 
 
We used WGS and patient questionnaire data to investigate gonorrhoea transmission in Brighton over 
a nine-month period. Even within this relatively small study sample, most infections (56/84, 67%) 
could be plausibly linked to another case through recent direct or indirect transmission. Unlinked 
cases in our study can be explained by patients who did not consent to provide questionnaire data, 
culture-negative patients and sources of infection outside Brighton. Some highly mobile individuals 
have sexual encounters and seek sexual health care in other cities and countries. As reported 
elsewhere, WGS has demonstrated transmission links between Brighton, other regions of the UK and 
the US10, highlighting the need for gonorrhoea control efforts to span regional and national 
boundaries.  
 
Brighton has a large MSM population and relatively high rates of gonorrhoea and also HIV.  We 
found clusters of plausibly linked gonorrhoea cases that included patients of mixed HIV-serostatus.  
Although some of our participants may have selected partners according to HIV-status our results 
provide evidence that serosorting was not consistently practiced.  This may be related to lower risk 
thresholds associated with chemsex5. Another explanation is use of HIV pre-exposure prophylaxis 
(PrEP): a PrEP effectiveness study (PROUD) was in progress in Brighton during the study period.  
Additionally, individuals may feel less motivated to use a condom with a serodiscordant partner if the 
HIV-positive partner is receiving antiretroviral therapy (ART).  The Partner study reported no linked 
HIV transmission in HIV serodiscordant couples during 16,400 episodes of sex where the HIV-
positive partner received ART and viral load was <200copies/ml9. We did not collect data on strategic 
positioning, which has been reported to be a common practice in highly sexually active HIV-negative 
MSM14.  We also found evidence of bridging of infection between heterosexuals and MSM.  One 
cluster (cluster 3) included highly related (2-3 SNPs) isolates from three heterosexual men and one 
isolate from an MSM. The MSM isolate differed by 9 SNPs from the heterosexual sub-cluster, 
suggesting the existence of missing links with the heterosexual group.   
 
Our results suggest that WGS of pathogens can be used to support conventional epidemiology in 
defining and characterising core transmitters15,16 and allow better targeted and more effective control 
efforts to reduce transmission.  Our approach allows identification of risk factors, one being the use of 
mobile geosocial networking applications to facilitate contact. Utilising phone apps to transmit 
prevention messages, STI testing information and to undertake partner notification should be 
explored. Educational messages and substance misuse services focused on chemsex may also have the 
potential to reduce frequency of partner change and risk taking behaviour. Public Health England 
released a briefing document for commissioners and providers of drug and alcohol services containing 
information about chemsex17.  New HIV diagnoses in the over 50s have doubled over the last 
decade18.   
 
One individual had two distinct N. gonorrhoeae strains, with different antimicrobial resistance 
patterns, in different anatomical sites suggesting they were part of two distinct transmission chains. 
This is consistent with the previous finding, based on WGS, that 13% of Brighton patients had distinct 
infections at different anatomical sites10, and highlights the importance of triple site testing, as well as 
antimicrobial resistance testing, in MSM.  
 
We aimed to test the feasibility of using WGS data coupled with patient questionnaire data to 
characterise sexual networks. A limitation is that we did not formally investigate congruence of WGS-
defined clusters with partner notification records.  Nevertheless, WGS and epidemiological results are 
broadly mutually supportive.  Our findings may not be generalisable to other locations, especially 
where gonorrhoea occurs more commonly in heterosexual populations. Another limitation is that we 
obtained both WGS data and questionnaire data from only a subset of patients presenting with 
gonorrhoea.  However, we believe selection bias may be minimal as the demographics of the study 
population correlate with the demographics of the general population experiencing gonorrhoea in 
Brighton based on local Genito-Urinary Medicine Clinic Activity Dataset (GUMCAD)19 data. It is 
possible that participants may have underreported their risk-taking behaviour, such as slamming, sex 
parties use of commercial sex workers, which may lead to a reporting bias, although to minimize this 
the questionnaires were self-administered and anonymous. 
 
This study raises questions about whether HIV serosorting has declined as a practice and why this 
might be. It has highlighted common risk factors such as chemsex and mobile phone apps to facilitate 
sex amongst MSM, both of which could be suitable targets for tailored interventions. We also found 
evidence of bridging between populations: it is plausible that interventions that reduce transmission in 
MSM may have wider impact in the general population. Genome sequencing is becoming 
increasingly accessible and offers opportunities to improve the investigation and control of 
gonorrhoea.  
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